Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers

Stroke

Volumn 30, Issue 1, 1999, Pages 140-147

  Thai, Quoc Anh ^a   Oshiro, Eric M ^a   Tamargo, Rafael J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cell adhesion molecules; Ibuprofen; Inflammation; Polymers; Vasospasm

Indexed keywords

CELL ADHESION MOLECULE; ETHYLENE VINYL ACETATE COPOLYMER; IBUPROFEN; MONOCLONAL ANTIBODY; POLYMER;

ADVENTITIA; ANIMAL MODEL; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE MIGRATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION; VASOSPASM;

EID: 0032908502     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.1.140     Document Type: Article

References (50)

1. Tamargo RJ, Walter KA, Oshiro EM. Aneurysmal subarachnoid hemorrhage: prognostic features and outcomes. New Horiz. 1997;5:364-375.
2. Handa Y, Kubota T, Kaneko M, Tsuchida A, Kobayashi H, Kawano H, Kubota T. Expression of intercellular adhesion molecule 1 (ICAM-1 ) on the cerebral artery following subarachnoid hemorrhage in rats. Acta Neurochir (Wien). 1995;132:92-97.
3. Sills AK Jr, Clatterbuck RE, Thompson RC, Cohen PL, Tamargo RJ. Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery. 1997;41:453-461.
4. Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ. Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke. 1997;28:2031-2038.
5. Kapiotis S, Sengoelge G, Sperr WR, Baghestanian M, Quehenberger P, Bevec D, Li SR, Menzel EJ, Muhl A, Zapolska D, Virgolini I, Valent P, Speiser W. Ibuprofen inhibits pyrogen dependent expression of VCAM-1 and ICAM-1 on human endothelial cells. Life Sci. 1996;58:2167-2181.
6. Nielsen VG, Webster RO. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen. Immunopharmacology. 1987;13:61-71.
7. Austyn JM, Wood KM. Principles of Cellular and Molecular Immunology. Oxford, England: Oxford University Press; 1993.
8. Diaz-Gonzalez F, Sanchez-Madrid F. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol Today. 1998;19:169-172.
9. Abramson S, Korchak H, Ludewig R, Edelson H, Haines K, Levin RI, Herman R, Rider L, Kimmel S, Weissmann G. Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA. 1985;82:7227-7231.
10. Chyatte D, Rusch N, Sundt TM. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. J Neurosurg. 1983;59:925-932.
11. Chyatte D. Prevention of chronic vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke. 1989;20:1021-1026.
12. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature. 1976;263:797-799.
13. Langer R. New methods of drug delivery. Science. 1990;249:1527-1533.
14. Tamargo RJ, Brem H. Drug delivery to the central nervous system: a review. Neurosurg Q. 1992;2:259-279.
15. Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H. Interstitial chemotherapy of the 9L gliosarcoma: controlled-release polymers for drug delivery in the brain. Cancer Res. 1993;53:329-333.
16. Tamargo RJ, Langer R, Brem H. Interstitial drug delivery to the central nervous system using controlled-release polymers: chemotherapy for brain tumors. Methods Neurosci. 1994;21:135-149.
17. Okada T, Harada T, Bark DH, Mayberg MR. A rat femoral artery model of vasospasm. Neurosurgery. 1990;27:349-356.
18. Robinson AP, White TM, Mason DW. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 1986;57:239-247.
19. Rousseaux P, Scherpereel B, Bernard MH, Graftieaux JP, Guyot JF. Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surg Neurol. 1980;14:459-465.
20. Weir B, Disney L, Grace M, Roberts P. Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery. 1989;25:161-165.
21. Crompton MR. The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain. 1964;87:491-510.
22. Hughes JT, Schianchi PM. Cerebral artery spasm: a histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg. 1978;48:515-525.
23. Tanabe Y, Sakata K, Yamada Y. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. J Neurosurg. 1978;49:229-238.
24. Peterson JW, Kwun BD. Hackett JD, Zervas NT. The role of inflammation in experimental vasospasm. J Neurosurg. 1990;72:767-774.
25. Handa Y, Kabuto M, Kobayashi H, Kawano H, Takeuchi H, Hayashi M. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery. 1991;28:542-549.
26. Pellettieri L, Carlson CA, Lindholm L. Is the vasospasm following subarachnoid hemorrhage an immunoreactive disease? Experientia. 1981;37: 1170-1171.
27. Hoshi T, Shimizu T, Kito K, Yamasaki N, Takahashi K, Takahashi M, Okada T, Kasuya H, Kitamura K. Immunological study of late cerebral vasospasm in subarachnoid hemorrhage: detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immunofluorescence method [in Japanese]. Neurol Med Chir (Tokyo). 1984;24:647-654.
28. Pellettieri L, Nilsson B, Carlsson CA, Nilsson U. Serum immuno-complexes in patients with subarachnoid hemorrhage. Neurosurgery. 1986;19:767-771.
29. Ostergaard JR, Kristensen BO, Svehag SE, Teisner B, Miletic T. Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg. 1987;66:891-897.
30. Kasuya H, Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg. 1989;71:741-746.
31. Yamakawa K, Sasaki T, Tsubaki S, Nakagomi T, Saito I, Takakura K. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 1991;31:24-31.
32. Peterson JW, Nishizawa S, Hackett JD, Bun T, Teramura A, Zervas NT. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke. 1990;21:133-137.
33. German JW, Gross CE, Giclas P, Watral W, Bednar MM. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery. 1996;39:141-146.
34. Nagata K, Sasaki T, Mori T, Nikaido H, Kobayashi E, Kim P, Kirino T. Cisternal talc injection in dog can produce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically. Surg Neurol. 1996;45:442-447.
35. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 1994;25:202-211.
36. Apstein CS, Vogel WM. Coronary arterial vasodilator effect of ibuprofen. J Pharmacol Exp Ther. 1982;220:167-171.
37. Askholt J, Nielsen-Kudsk R. Ibuprofen, pharmacokinetics and pharmacodynamics in the isolated rabbit heart. Acta Pharmacol Toxicol. 1985; 56:99-107.
38. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
39. Handa Y, Weir BKA, Nosko M, Mosevich R, Tsuji T, Grace M. The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg. 1987;67:558-564.
40. Nosko M, Weir BKA, Lunt A, Grace M, Allen P, Mielke B. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg. 1987;66:416-422.
41. Findlay JM, Weir BKA, Kanamaru K, Grace M, Baughman R. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery. 1990;26:201-206.
42. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med. 1990;172:1741-1748.
43. Sessa WC, Kaw S, Hecker M. Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1991;174:613-618.
44. Janeway CA, Travers P. Immunobiology: The Immune System in Health and Disease. New York. NY: Current Biology Ltd/Garland Publishing, Inc; 1996.
45. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79: 319-326.
46. Faraci FM. Endothelium-derived vasoactive factors and regulation of the cerebral circulation. Neurosurgery. 1993;33:648-659.
47. Hino T, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, Macdonald RL. Changes in endothelial nitric oxide synthase m RNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery. 1996;39:562-568.
48. Zabramski JM. Vasospasm After Subarachnoid Hemorrhage. Park Ridge, Ill: American Association of Neurological Surgeons; 1997.
49. Akopov SE, Grigorian MR, Gabrielian ES. The endothelium-dependent relaxation of human middle cerebral arteries: effects of activated neutrophils. Experientia. 1992;48:34-36.
50. Csaki C, Szabo C, Benyo Z, Reivich M, Kovach AGB. Activated neutrophils inhibit cerebrovascular endothelium-dependent relaxations in vitro. Life Sci. 1991;49:1087-1094.